6.27
-0.91 (-12.67%)
| Previous Close | 7.18 |
| Open | 6.64 |
| Volume | 1,145,941 |
| Avg. Volume (3M) | 1,154,562 |
| Market Cap | 321,483,808 |
| Price / Earnings (Forward) | 22.99 |
| Price / Sales | 0.490 |
| Price / Book | 1.00 |
| 52 Weeks Range | |
| Earnings Date | 2 Nov 2026 |
| Profit Margin | -13.63% |
| Operating Margin (TTM) | 22.68% |
| Diluted EPS (TTM) | -2.58 |
| Quarterly Revenue Growth (YOY) | -26.00% |
| Quarterly Earnings Growth (YOY) | 655.60% |
| Total Debt/Equity (MRQ) | 121.71% |
| Current Ratio (MRQ) | 6.32 |
| Operating Cash Flow (TTM) | 110.10 M |
| Levered Free Cash Flow (TTM) | 91.12 M |
| Return on Assets (TTM) | -1.61% |
| Return on Equity (TTM) | -21.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Emergent BioSolutions Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Relative Valuation | 5.0 |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | 0.78 |
Select this tab to load the latest available analysis.
|
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 2.83% |
| % Held by Institutions | 67.20% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DEGOLYER DONALD W | - | 7.07 | -17,800 | -125,846 |
| Aggregate Net Quantity | -17,800 | |||
| Aggregate Net Value ($) | -125,846 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 7.07 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DEGOLYER DONALD W | Director | 07 Oct 2026 | Automatic sell (-) | 17,800 | 7.07 | 125,846 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |